Eikon Therapeutics Email Format

Biotechnology Research
201-500 employees
Millbrae, CA, USA

Eikon Therapeutics is a late-stage clinical biopharmaceutical company developing novel therapies for oncology and neurological diseases using single-molecule imaging and machine learning.

Find contacts at Eikon Therapeutics

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

lastfirstinitial@eikontx.com

Company Overview

Industry
Biotechnology Research
Founded
2019
Headquarters
Millbrae, CA, USA
Revenue
$25M-$50M
FUNDING Stage
Private
Key Executives
Roger M. Perlmutter (Chief Executive Officer and Board Chair), Alfred Lloyd Bowie Jr. (Chief Financial Officer), Michael Klobuchar (Chief Operating Officer)

Tech Stack

Okta

Infrastructure

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Eikon Therapeutics?

Eikon Therapeutics uses the firstinitiallast format, so Jane Smith would be jsmith@eikontx.com.

What therapeutic areas does Eikon Therapeutics focus on in its clinical pipeline?

Eikon Therapeutics is primarily focused on oncology, with additional programs in immunology and neuroscience. Its clinical-stage pipeline includes candidates targeting TLR7/8, PARP1, and WRN helicase across tumor types such as NSCLC, melanoma, breast, ovarian, and prostate cancers.

How does Eikon Therapeutics use its single molecule tracking platform to discover drugs?

Eikon Therapeutics uses its proprietary single molecule tracking platform to visualize hundreds of thousands of protein motion events in living cells in under a second, enabling the identification of novel drug candidates that traditional methods would miss.

Who leads Eikon Therapeutics as CEO?

Roger M. Perlmutter serves as Chief Executive Officer and Board Chair of Eikon Therapeutics. He brings more than 35 years of industry and academic experience, including a previous role as Executive Vice President at Merck.

Can Clay help find and verify contact information for Eikon Therapeutics employees?

Yes, Clay can help you find and verify email addresses for Eikon Therapeutics contacts by applying the firstinitiallast pattern against the eikontx.com domain, making it straightforward to build and enrich a prospect list of the company's 409 employees.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles